Liver pathology in compound heterozygous patients for hemochromatosis mutations.


BACKGROUND While hepatic pathology of homozygous carriers of the C282Y mutation of the HFE haemochromatosis gene is well defined, the impact of the C282Y/H63D compound heterozygous carrier state is unknown. AIMS To evaluate the range of hepatic pathology in C282Y/H63D compound heterozygous patients. PATIENTS 25 C282Y/H63D compound heterozygous patients… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics